AI Tool LabGym Takes a Shot at Analyzing Animal Behavior
A group of researchers at the University of Michigan have developed user-friendly artificial-driven software called as LabGym. This software automatically analyzes animal behavior. This model would be very much useful in developing life science and drug development in near future….
New Biomarker to Diagnose Vascular Dementia
Sometimes it can be challenging for doctors to detect whether the patient’s cognitive impairment originates from Alzheimer’s disease or vascular problems. These are the two major reasons to cause vascular dementia. Usually, doctors rely on MRI or CAT scans to…
An In-Vitro Fully Human Ovarian Organoid Supporting Egg Cell Maturation
We all start as egg cells in our mother’s ovaries. Scientists have been working on generating in vitro models for the ovaries so that we can study more about them since the female reproductive organs are surprisingly understudied till now….
Bond Villain DNA: The game changer for cancer treatment
A group of researchers have found the pieces of DNA that help cancer to spread hence called to be ‘Bond Villain’. This segment of genetic material known as Extrachromosomal DNA or ecDNA was found by scientists, working on a project…
Alzheimer’s Disease Hallmarks Decrease on Removal of Neuronal Lipoprotein in Mice.
Cholesterol is the main structural component of the brain and it is transported and distributed through the Central Nervous System (CNS) with the help of the lipid metabolic cycle. Alzheimer’s disease (AD) patients often suffer through ‘Multimorbidity’ (meaning: multiple chronic…
Xylazine Drug Turning Humans into Zombies in US
A new drug named Xylazine or Tranq has caused a major havoc in different cities across US by severe symptoms like skin rotting a.k.a zombie like effect. This ‘zombie drug’ has been approved by the country’s Food and Drug Administration…
3rd Patient got free from HIV after receiving Antiretroviral Therapy (ART)
A 53-year-old man who was diagnosed with the deadly virus HIV in 2008 is now recovering from the virus with the help of stem cell transplant therapy as reported in the journal Nature Medicine. “The Düsseldorf patient,” is reportedly the 3rd…
Celltrion and LISCure Biosciences to develop unique microbiome treatment for Parkinson’s disease
LISCure Biosciences Inc., a clinical-stage biotech is developing advanced microbiome technology with accurate targets and announced a multi-year strategic R&D collaboration with Celltrion to identify novel microbiome therapy for neurodegenerative diseases like Parkinson’s disease. – Co-research and co-development of novel microbiome…
How Regulatory T cells impact on self-reactive T cells
There are 3 main types of T cells: Cytotoxic, helper, and regulatory T cells. Cytotoxic T cells have CD8 as a co-receptor on their cell surface whereas, CD4+ T cells are divided into Regulatory T cells (Treg) and Helper T…
How Artificial Intelligence will change biology
Artificial intelligence (AI) is already beginning to have a significant impact on the field of biology, and it is poised to change the field in a number of ways. Analysis of large datasets One major area where AI is having…
